Seattle is the latest city to open walk-up kiosks for COVID-19 testing that allow individuals to collect their own saliva, then hand the specimen to a worker in the booth for overnight testing. Three such kiosks are now in operation. Curative, based in San Dimas, Calif., performs the testing using a molecular SARS-CoV-2 test that has an FDA EUA. The walk-up kiosks are part of a COVID-19 testing program run by the City of Seattle. A statement on the city’s website says, “COVID-19 tests are free. Insurance is not required. If you have insurance, Medicare or Medicaid, you must provide this information and UW Medicine will bill them. You will not be charged.”
LABCORP ACQUIRES ANALYTICS FIRM VISIUN, INC.
In a little-noticed transaction, LabCorp acquired Visiun Inc., of Ann Arbor, Mich., one of the largest providers of an analytics middleware solution for clinical laboratory operations and workflow. The parties did not respond to The Dark Report’s requests for comment as of press time, but a notice on the Visiun website says the acquisition was completed on Dec. 1. This is an interesting development that could have significant ramifications. Visiun provides near-real-time analytics to hundreds of hospital and health system laboratories.
MORE ON: LabCorp’s Acquisition of Visiun
Among Visiun’s clients are some of the nation’s best lab operations. Visiun has developed benchmarking and best-practices based on the performances of hundreds of its lab clients. As Visiun’s new owner, LabCorp now has access to that performance data. Lab administrators should keep in mind that LabCorp had business reasons for acquiring Visiun and the performance information it gathers. Might LabCorp believe it now has a potentially game-changing advantage, particularly in markets where a hospital or health system has a highly-effective laboratory outreach business?
• Pathologist Ana K. Stankovic, MD, PhD, MSPH, was appointed to the Board of Directors by Fluidigm Corporation of San Francisco. She is currently Managing Director at Koliada Consulting and previously held positions with Becton Dickinson, University of Vanderbilt School of Medicine, Quest Diagnostics, and the Division of Laboratory Services at the Centers for Disease Control and Prevention.
• Rhinostics of Cambridge, Mass., announced that Cheri Walker is its new President and CEO. Walker earlier held executive positions at Abcam, Kailos Genetics, Charles River Laboratories, Qiagen, Invitrogen, and Deutsche Bank.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, January 18, 2021.